Rule 39 Attendance of the public at hearingsI1
England, Wales and Scotland
Except as provided for in this rule, hearings of the Committee must be held in public.
Any hearing before the Committee relating to a health allegation, or an interim order hearing before the Committee, must be held in private, unless the Committee is satisfied—
having given the parties (where present), and any third party from whom the Committee considers it appropriate to hear, an opportunity to make representations; and
in the case of the hearing relating to a health allegation, having obtained the advice of the legal and clinical advisers,
that the public interest in holding the hearing in public outweighs the interest of the registrant concerned or the third party in maintaining their privacy.
A hearing before the Committee other than a hearing referred to in paragraph (2) may be held wholly or partly in private if the Committee—
has given the parties (where present), and any third party from whom the Committee considers it appropriate to hear, an opportunity to make representations; and
is satisfied that the interest of the person concerned or the third party in maintaining their privacy outweighs the public interest in holding the hearing, or the part of the hearing, in public.
The Committee may exclude from the whole or part of any hearing any person whose conduct, in its opinion, has disrupted or is likely to disrupt the proceedings.
Reference to a hearing under this rule includes hearings conducted by teleconference or video link.
Annotations
Textual amendments
- F1
Sch. rule 39(5) inserted (6.10.2022) by The General Pharmaceutical Council (Amendment) Rules Order of Council 2022 (S.I. 2022/697), Sch. rules 1, 3(6)
Commencement
- I1
Sch. rule 39 in force at 27.9.2010, see Sch. rule 1
Notes on Schedule
Footnotes
- f1